Document is current

Any future updates will be listed below

The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent

Crossref DOI link: https://doi.org/10.1007/s11606-021-07000-3

Published Online: 2021-07-13

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark